Tempus AI Inc (TEM)

Currency in USD
55.53
-2.21(-3.83%)
Closed·
After Hours
55.97+0.44(+0.79%)
·
TEM Scorecard
Full Analysis
6 analysts have revised their earnings downwards for the upcoming period
Earnings results expected tomorrow
TEM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.8857.64
52 wk Range
31.3691.45
Key Statistics
Prev. Close
57.74
Open
57.62
Day's Range
54.88-57.64
52 wk Range
31.36-91.45
Volume
5.58M
Average Volume (3m)
12.29M
1-Year Change
36.53%
Book Value / Share
1.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TEM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
67.70
Upside
+21.92%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Tempus AI Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Tempus AI Inc Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue surged 75.4% YoY to $255.7M, beating forecasts. EPS of -$0.24 exceeded expectations despite stock decline.
  • Genomics revenue grew 89% YoY, oncology testing up 31%. Adjusted EBITDA improved to -$16.2M from -$43.9M in Q1 2024.
  • Full-year 2025 revenue guidance raised to $1.25B, projecting 80% YoY growth. Company expects to be EBITDA positive in 2025.
  • Focus on AI and data infrastructure, developing world's largest oncology foundation model. 40% XT volume migration to FDA-approved version targeted.
  • CEO emphasized AI as key differentiator in diagnostics. Analysts showed interest in foundation model collaboration and hereditary testing growth.
Last Updated: 06/05/2025, 22:18
Read Full Transcript

Compare TEM to Peers and Sector

Metrics to compare
TEM
Peers
Sector
Relationship
P/E Ratio
−13.3x−0.8x−0.5x
PEG Ratio
2.20−0.160.00
Price/Book
29.5x2.0x2.6x
Price / LTM Sales
12.0x1.9x3.3x
Upside (Analyst Target)
21.5%69.3%43.5%
Fair Value Upside
Unlock26.0%6.9%Unlock

Analyst Ratings

6 Buy
6 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 67.70
(+21.92% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-0.40 / -0.26
Revenue / Forecast
255.74M / 248.50M
EPS Revisions
Last 90 days

TEM Income Statement

People Also Watch

161.71
CRCL
+5.05%
83.10
OKLO
-1.18%
17.580
QBTS
-3.93%
110.24
CRWV
-1.43%
18.930
JOBY
-2.87%

FAQ

What Stock Exchange Does Tempus AI Trade On?

Tempus AI is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tempus AI?

The stock symbol for Tempus AI is "TEM."

What Is the Tempus AI Market Cap?

As of today, Tempus AI market cap is 9.61B.

What Is Tempus AI's Earnings Per Share (TTM)?

The Tempus AI EPS (TTM) is -4.92.

When Is the Next Tempus AI Earnings Date?

Tempus AI will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is TEM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Tempus AI Stock Split?

Tempus AI has split 0 times.

How Many Employees Does Tempus AI Have?

Tempus AI has 2400 employees.

What is the current trading status of Tempus AI (TEM)?

As of 07 Aug 2025, Tempus AI (TEM) is trading at a price of 55.53, with a previous close of 57.74. The stock has fluctuated within a day range of 54.88 to 57.64, while its 52-week range spans from 31.36 to 91.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.